Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 715 | 748 | 1,039 | 1,555 | 951 |
| Operating Income | -715 | -748 | -1,039 | -1,555 | -951 |
| Other Income | 49 | 8 | 21 | 33 | 10 |
| Pre-tax Income | -667 | -741 | -1,017 | -1,522 | -941 |
| Net Income Continuous | -667 | -741 | -1,017 | -1,522 | -941 |
| Net Income | $-667 | $-741 | $-1,017 | $-1,522 | $-941 |
| EPS Basic Total Ops | -0.37 | -1.33 | -1.92 | -2.89 | -14.21 |
| EPS Basic Continuous Ops | -0.37 | -1.33 | -1.92 | -1.16 | -3.22 |
| EPS Diluted Total Ops | -0.37 | -1.33 | -1.92 | -2.89 | -14.21 |
| EPS Diluted Continuous Ops | -0.37 | -1.33 | -1.92 | -1.16 | -3.22 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.33 | -1.92 | N/A | -14.22 |
| EBITDA(a) | $-715 | $-748 | $-1,039 | $-1,555 | $-951 |